---
search:
  boost: 2 
---

# Other Agents

This is a subcategory of Respiratory Agents.

## Formulary

### Preferred

| Preferred | Generic Name | Quantity | Time (Days) |
| :-------- | :----------- | :------: | :---------: |
|           |              |          |             |

### Non-Preferred

| Non-Preferred           | Generic Name | Quantity | Time (Days) |
| :---------------------- | :----------- | :------: | :---------: |
| Daliresp <sup>BvG</sup> |              |          |             |

## Length of Authorizations

Initial: 90 days

Subsequent: 180 days

## All Authorizations

Must be prescribed in accordance with FDA approved labeling

## Non-Preferred Criteria

- Must provide documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances) **OR**
    - For any nonsolid oral dosage formulation: must provide documentation of medical necessity for why patient cannot be changed to a solid oral dosage formulation
- Must have had an inadequate clinical response to at least **90 days** with at least **one preferred** long-acting beta agonist **AND one preferred** long-acting muscarinic antagonist-containing inhalers
    - For non-preferred extended-release formulations: must provide documentation of an inadequate clinical response with its immediate release formulation (if available)
    - For non-preferred brand names that have preferred generics: must provide documentation of an inadequate clinical response or allergy to two or more generic labelers (if available)

## Roflumilast (Daliresp)

Additional Roflumilast (Daliresp) Criteria

- Must be used in addition to a long-acting beta agonist AND a long-acting muscarinic antagonist-containing inhalers 

## Subsequent Authorization Criteria

- Must provide documentation of patient's clinical response to treatment, adherence to maintenance inhaler per pharmacy claims, and ongoing safety monitoring

## Links

[Criteria](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_UPDL%20_Criteria_APPROVED.pdf#page=99)

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_UPDL_APPROVED_12.13.22.pdf#page=32)

[Quantity Limit List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_Ohio_Medicaid_Quantity_Document_APPROVED.pdf)
